Research Biobank From Neuromuscular Biopsy Residues (in the Context of Care)
COLMYONEU
Constitution of a Collection of Residues of Neuromuscular Biopsies From Patients Taken as Part of Their Health Care at the Bordeaux University Hospital for Neuromuscular Disease and Use for Research Projects
1 other identifier
observational
500
1 country
1
Brief Summary
Neuromuscular diseases are rare diseases for which significant progress has been made in the context of diagnosis thanks to advances in molecular techniques, but the intimate mechanisms of lesion formation remain poorly understood. Advances in cellular and molecular biology, the development of a few animal models, such as transgenic mice, which make it possible to mimic human pathology have made it possible to better understand the physiopathology of these diseases. However, they still do so very imperfectly and incompletely, making it even more necessary than ever to study diseased human muscle tissue to find new avenues of research or to confirm results obtained by experimentation. The purpose of this collection of tissue samples for neuro-muscular purposes is to collect such samples under the best conditions in order to promote basic and translational research on muscle diseases. This is why the CHU de Bordeaux wishes to keep the remainders of samples taken as part of the treatment to constitute a collection of biological samples and associated data kept according to quality standards and in compliance with the regulations in force.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 26, 2023
CompletedFirst Submitted
Initial submission to the registry
August 17, 2023
CompletedFirst Posted
Study publicly available on registry
October 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 25, 2053
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 25, 2053
October 10, 2023
August 1, 2023
30 years
August 17, 2023
October 5, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Constitution of a biocollection
Collection of leftover frozen neuromuscular biopsy samples from patients taken as part of their health care at the Bordeaux University Hospital for neuromuscular disease.
30 years
Study Arms (1)
Constitution of biocollection
Collection of remains of neuromuscular biopsy samples (nerve and muscles)
Interventions
recovery of residual neuromuscular biopsy (nerve ans muscle)
Eligibility Criteria
patients with neuromuscular symptoms.
You may qualify if:
- Patients treated at Bordeaux University Hospital (neurology services, neuropediatrics), rheumatology, medical genetics for suspected neuromuscular disease.
- Men and women are affected, adults and minors.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Université Hospital, Bordeaux
Bordeaux, 33000, France
Biospecimen
collection of remains of neuromuscular biopsy samples (nerve and muscles)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marie Laure NEGRIER, Pr
Université Hospital, Bordeaux
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 17, 2023
First Posted
October 10, 2023
Study Start
June 26, 2023
Primary Completion (Estimated)
June 25, 2053
Study Completion (Estimated)
June 25, 2053
Last Updated
October 10, 2023
Record last verified: 2023-08